Aroa Biosurgery has been growing earnings at an average annual rate of 30.6%, while the Biotechs industry saw earnings growing at 33.8% annually. Revenues have been growing at an average rate of 26.4% per year.
Key information
30.59%
Earnings growth rate
60.27%
EPS growth rate
Biotechs Industry Growth
17.04%
Revenue growth rate
26.39%
Return on equity
-1.97%
Net Margin
-2.01%
Next Earnings Update
25 May 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Aroa Biosurgery makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:AROA.F Revenue, expenses and earnings (NZD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Sep 25
90
-2
69
8
30 Jun 25
88
-3
68
9
31 Mar 25
85
-4
67
10
31 Dec 24
81
-6
67
9
30 Sep 24
76
-8
68
9
30 Jun 24
73
-9
65
9
31 Mar 24
69
-11
62
9
31 Dec 23
67
-9
59
9
30 Sep 23
66
-8
56
10
30 Jun 23
65
-4
52
10
31 Mar 23
63
0
48
11
31 Dec 22
57
-1
42
11
30 Sep 22
51
-2
37
11
30 Jun 22
45
-5
34
10
31 Mar 22
40
-8
31
8
31 Dec 21
35
-10
28
8
30 Sep 21
31
-11
26
7
30 Jun 21
27
-15
24
7
31 Mar 21
22
-19
22
6
31 Dec 20
22
-19
21
6
30 Sep 20
21
-19
20
5
30 Jun 20
23
-12
18
5
31 Mar 20
25
-6
17
5
31 Mar 19
24
1
12
5
31 Mar 18
11
-1
4
3
Quality Earnings: AROA.F is currently unprofitable.
Growing Profit Margin: AROA.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AROA.F is unprofitable, but has reduced losses over the past 5 years at a rate of 30.6% per year.
Accelerating Growth: Unable to compare AROA.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AROA.F is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (43%).
Return on Equity
High ROE: AROA.F has a negative Return on Equity (-1.97%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/24 22:52
End of Day Share Price
2026/05/20 00:00
Earnings
2025/09/30
Annual Earnings
2025/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aroa Biosurgery Limited is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.